STXBP6 and B3GNT6 Genes are Associated With Selective IgA Deficiency
Immunoglobulin A Deficiency (IgAD) is a polygenic primary immune deficiency, with a strong genetic association to the human leukocyte antigen (HLA) region. Previous genome-wide association studies (GWAS) have identified five non-HLA risk loci ( IFIH1, PVT1 , ATG13-AMBRA1 , AHI1 and CLEC16A ). In thi...
Saved in:
Published in | Frontiers in genetics Vol. 12; p. 736235 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
17.12.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Immunoglobulin A Deficiency (IgAD) is a polygenic primary immune deficiency, with a strong genetic association to the human leukocyte antigen (HLA) region. Previous genome-wide association studies (GWAS) have identified five non-HLA risk loci (
IFIH1, PVT1
,
ATG13-AMBRA1
,
AHI1
and
CLEC16A
). In this study, we investigated the genetic interactions between different HLA susceptibility haplotypes and non-MHC genes in IgAD. To do this, we stratified IgAD subjects and healthy controls based on HLA haplotypes (
N
= 10,993), and then performed GWAS to identify novel genetic regions contributing to IgAD susceptibility. After replicating previously published HLA risk haplotypes, we compared individuals carrying at least one HLA risk allele (
HLA-B*08:01-DRB1*03:01-DQB1*02:01
or
HLA-DRB1*07:01-DQB1*02:02
or
HLA-DRB1*01-DQB1*05:01
) with individuals lacking an HLA risk allele. Subsequently, we stratified subjects based on the susceptibility alleles/haplotypes and performed gene-based association analysis using 572,856 SNPs and 24,125 genes. A significant genome-wide association in
STXBP6
(rs4097492;
p
= 7.63 × 10
−9
) was observed in the cohort carrying at least one MHC risk allele. We also identified a significant gene-based association for
B3GNT6
(
P
Gene
= 2.1 × 10
–6
) in patients not carrying known HLA susceptibility alleles. Our findings indicate that the etiology of IgAD differs depending on the genetic background of HLA susceptibility haplotypes. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Mikko Risto Juhana Seppänen, Helsinki University Central Hospital, Finland Reviewed by: Javier Martin, Instituto de Parasitología y Biomedicina López-Neyra (IPBLN), Spain Xiao Chang, Children’s Hospital of Philadelphia, United States This article was submitted to Applied Genetic Epidemiology, a section of the journal Frontiers in Genetics |
ISSN: | 1664-8021 1664-8021 |
DOI: | 10.3389/fgene.2021.736235 |